Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
LAT4 drives temozolomide induced radiotherapy resistance in glioblastoma by enhancing mTOR pathway activation
Wenrui Zang
Yangwu Liu
Jiajun Zheng
Yifeng Huang
Lei Chen
Chiyang Li
Jiakun Zhao
Qiang Zhou
Yangheng Xu
Zhenyuan Wang
Yongfu Cao
Wanling Zhang
Junjie Li
Yuntao Lu
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1186/s12935-024-03590-0
Dec 18, 2024
Version published to 10.21203/rs.3.rs-4913708/v1 on Research Square
Oct 14, 2024
Related articles
PARP inhibitor counteracts Temozolomide Resistance in Glioblastoma Multiforme
This article has 9 authors:
Edouard Samarut
Tabourel Gaston
Briand Joséphine
Landais Yuna
Gratas Catherine
Cartron Pierre-François
Vallette François
Oliver Lisa
Sérandour A. Aurélien
Targeting Snail2 improve sensitivity to parthenolide in T-cell acute lymphoblastic leukemia through PUMA activation
This article has 3 authors:
cuiming cao
YAWEI ZHOU
WEICHEN WANG
FGFR1 inhibition improves therapy efficacy and prevents metabolic adaptation associated with temozolomide resistance in glioblastoma
This article has 16 authors:
Laura Zarzuela
Ignacio G. López-Cepero
Kevin M. Rattigan
Elena Sánchez-Escabias
Macarena Morillo-Huesca
Ana Reina-Bando
Sara S. Oltra
Jesús M. Sierra-Párraga
María Ceballos-Chávez
Vivian Capilla-González
Gema Moreno-Bueno
Piedad del Socorro Murdoch
José C. Reyes
G. Vignir Helgason
Mercedes Tomé
Raúl V. Durán
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up